✦ LIBER ✦

Treatment of acquired haemophilia with recombinant activated FVII: a critical appraisal

✍ Scribed by M. J. SUMNER; B. D. GELDZILER; M. PEDERSEN; S. SEREMETIS

Book ID: 108772791
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 470 KB
Volume: 13
Category: Article
ISSN: 1351-8216
DOI: 10.1111/j.1365-2516.2007.01474.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Congenital factor VII deficiency: therap

Congenital factor VII deficiency: therapy with recombinant activated factor VII – a critical appraisal

✍ G. MARIANI; B. A. KONKLE; J. INGERSLEV 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB

Treatment of acquired haemophilia with f

Treatment of acquired haemophilia with factor eight inhibitor bypassing activity

✍ S. Sallah 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 52 KB

**Summary.** Haemorrhagic manifestations in patients with acquired haemophilia can be fatal if not recognized and treated appropriately. A retrospective analysis of the efficacy of factor eight inhibitor bypassing activity (FEIBA) in patients with acquired haemophilia treated in three medical centre

A critical appraisal of the use of recom

A critical appraisal of the use of recombinant factor VIIa in acquired bleeding conditions

✍ Sajjan Mittal; Henry G. Watson 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB

Successful prophylactic use of recombina

Successful prophylactic use of recombinant activated factor VII (rFVIIa) in a patient with congenital FVII deficiency and inhibitors to FVII

✍ H. TOKGOZ; U. CALISKAN; G. LAVIGNE-LISSALDE; M. GIANSILY-BLAIZOT 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB

Efficacy of different doses of recombina

Efficacy of different doses of recombinant activated factor VII in the treatment of haemophilia children with inhibitor

✍ A. CHUANSUMRIT; N. SIRACHAINAN; S. PAKAKASAMA; A. SUEBSANGAD; S. CHOTSUPPAKARN; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 44 KB

Prophylactic treatment of haemophilia pa

Prophylactic treatment of haemophilia patients with inhibitors: clinical experience with recombinant factor VIIa in European Haemophilia Centres

✍ M. MORFINI; G. AUERSWALD; R. A. KOBELT; G. F. RIVOLTA; J. RODRIGUEZ-MARTORELL; F 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 471 KB